Background: One of the many reasons why lesional surgery for movement disorders has been more or less abandoned may have been the difficulty in predicting the shape and size of the stereotactic radiofrequency (RF) lesion. Objectives: To analyse the contribution of various RF coagulation parameters towards the volume of pallidotomies and thalamotomies. Methods: The relationship between temperature of coagulation, length of coagulated area and duration of coagulation on the one hand, and lesion volume on the other was retrospectively evaluated. Lesion diameters were measured on stereotactic thin-slice CT and MRI scans, and volumes of lesions were calculated concerning 36 pallidotomies and 14 thalamotomies in 46 patients who were operated using the same RF generator and same RF electrode. Results: The coagulation temperature, length of coagulated area and duration of coagulation were all correlated to the lesion volume. However, for a given length of coagulated area, the lesion´s size was most strongly influenced by the temperature. Despite this clear correlation, and the relatively homogenous coagulation parameters, the lesions’ volumes were markedly scattered. Conclusions: The volume of the stereotactic RF lesions could be correlated with the coagulation parameters, especially the temperature, at a group level, but could not be predicted in individual patients based solely on the RF coagulation parameters.

1.
Patel NK, Heywood P, O’Sullivan K, McCarter R, Love S, Gill SS: Unilateral subthalamotomy in the treatment of Parkinson’s disease. Brain 2003;126:1136–1145.
2.
Alvarez L, Macias R, Guridi J, Lopez G, Alvarez E, Maragoto C, Teijeiro J, Torres A, Pavon N, Rodriguez-Oroz MC, Ochoa L, Hetherington H, Juncos J, DeLong MR, Obeso JA: Dorsal subthalamotomy for Parkinson’s disease. Mov Disord 2001;16:72–78.
3.
Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, Juncos JL, Maragoto C, Guridi J, Litvan I, Tolosa ES, Koller W, Vitek J, DeLong MR, Obeso JA: Bilateral subthalamotomy in Parkinson’s disease: initial and long-term response. Brain 2005;128:570–583.
4.
Blomstedt P, Hariz MI: Are complications less common in deep brain stimulation than in ablative procedures for movement disorders? Stereotact Funct Neurosurg 2006;84:72–81.
5.
Blomstedt P, Hariz GM, Hariz MI: Pallidotomy versus pallidal stimulation. Parkinsonism Relat Disord 2006;12:296–301.
6.
Burchiel KJ: Thalamotomy for movement disorders. Neurosurg Clin North Am 1995;6:55–71.
7.
Laitinen LV, Bergenheim AT, Hariz MI: Leksell’s posteroventral pallidotomy in the treatment of Parkinson’s disease. J Neurosurg 1992;76:53–61.
8.
Hariz MI, Hirabayashi H: Is there a relationship between size and site of the stereotactic lesion and symptomatic results of pallidotomy and thalamotomy? Stereotact Funct Neurosurg 1997;69:28–45.
9.
Hirabayashi H, Hariz M, Fagerlund M: Comparison between stereotactic CT and MRI coordinates of pallidal and thalamic targets using the Laitinen noninvasive stereoadapter. Stereotact Funct Neurosurg 1998;71:117–130.
10.
Hariz M, Laitinen L: The Laitinen apparatus; in Gildenberg PL, Tasker R (eds): Textbook of Stereotactic and Functional Neurosurgery. New York, McGraw-Hill, 1996, pp 87–94.
11.
Kelly PJ, Gillingham FJ: The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson’s disease. A 10-year follow-up study. J Neurosurg 1980;53:332–337.
12.
Cooper I: Chemopallidectomy. Science 1955;121:217–218.
13.
Narabayashi H, Okuma T: Procaine oil blocking of the globus pallidus for the treatment of rigidity and tremor of parkinsonism. Proc Jpn Acad 1953;29:310–318.
14.
Cooper IS, Lee AS: Cryostatic congelation: a system for producing a limited, controlled region of cooling or freezing of biologic tissues. J Nerv Ment Dis 1961;133:259–263.
15.
Mundinger F, Riechert T, Gabriel E: Untersuchungen zu den physikalischen und technischen Voraussetzungen einer dosierten Hochfrequenzkoagulation bei stereotaktischen Hirnoperationen. Zentralbl Chir 1960;85:1051–1063.
16.
Gildenberg PL: The history of stereotactic and functional neurosurgery; in Gildenberg PL, Tasker R (eds): Textbook of Stereotactic and Functional Neurosurgery. New York, McGraw-Hill, 1996, pp 5–19.
17.
Sweet WH, Mark VH: Unipolar anodal electrolytic lesions in the brain of man and cat: report of five human cases with electrically produced bulbar or mesencephalic tractotomies. AMA Arch Neurol Psychiatry 1953;70:224–234.
18.
Cosman ER Sr, Cosman ER Jr: Radiofrequency lesions; in Lozano A, Gildenberg PL, Tasker R (eds): Textbook of Stereotactic and Functional Neurosurgery. Berlin, Springer, 2009, pp 1359–1382.
19.
Walder HA, Jaspar HH: The type of lesion produced in stereotactic operations. Psychiatr Neurol Neurochir 1970;73:353–364.
20.
Organ LW: Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol 1976;39:69–76.
21.
Vinas FC, Zamorano L, Dujovny M, Zhao JZ, Hodgkinson D, Ho KL, Ausman JI: In vivo and in vitro study of the lesions produced with a computerized radiofrequency system. Stereotact Funct Neurosurg 1992;58:121–133.
22.
Eriksson O, Backlund EO, Lundberg P, Lindstam H, Lindstrom S, Wardell K: Experimental radiofrequency brain lesions: a volumetric study. Neurosurgery 2002;51:781–787.
23.
Johansson JD, Eriksson O, Wren J, Loyd D, Wardell K: Radio-frequency lesioning in brain tissue with coagulation-dependent thermal conductivity: modelling, simulation and analysis of parameter influence and interaction. Med Biol Eng Comput 2006;44:757–766.
24.
Hassler R, Mundinger F, Riechert T: Stereotaxis in Parkinson syndrome with an atlas of the basal ganglia; in Hassler R (ed): Parkinsonism. Berlin, Springer, 1979.
25.
Iacono RP, Osborne DR, Nashold BS Jr: CT analysis of stereotactic thalamotomy. Adv Neurol 1984;40:453–458.
26.
Dogali M, Fazzini E, Kolodny E, Eidelberg D, Sterio D, Devinsky O, Beric A: Stereotactic ventral pallidotomy for Parkinson’s disease. Neurology 1995;45:753–761.
27.
Dogali M, Sterio D, Fazzini E, Kolodny E, Eidelberg D, Beric A: Effects of posteroventral pallidotomy on Parkinson’s disease. Adv Neurol 1996;69:585–590.
28.
Lozano AM, Lang AE, Galvez-Jimenez N, Miyasaki J, Duff J, Hutchinson WD, Dostrovsky JO: Effect of GPI pallidotomy on motor function in Parkinson’s disease. Lancet 1995;346:1383–1387.
29.
Beric A, Sterio D, Dogali M, Alterman R, Kelly P: Electrical stimulation of the globus pallidus preceding stereotactic posteroventral pallidotomy. Stereotact Funct Neurosurg 1996;66:161–169.
30.
De Salles AA, Brekhus SD, De Souza EC, Behnke EJ, Farahani K, Anzai Y, Lufkin R: Early postoperative appearance of radiofrequency lesions on magnetic resonance imaging. Neurosurgery 1995;36:932–936.
31.
Iacono RP, Shima F, Lonser RR, Kuniyoshi S, Maeda G, Yamada S: The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson’s disease. Neurosurgery 1995;36:1118–1125.
32.
Alberts WW, Wright EW Jr, Feinstein B, Von Bonin G: Experimental radiofrequency brain lesion size as a function of physical parameters. J Neurosurg 1966;25:421–423.
33.
Moringlane JR, Koch R, Schafer H, Ostertag CB: Experimental radiofrequency (RF) coagulation with computer-based on line monitoring of temperature and power. Acta Neurochir 1989;96:126–131.
34.
Eriksson O, Wardell K, Bylund NE, Kullberg G, Rehncrona S: In vitro evaluation of brain lesioning electrodes (Leksell) using a computer-assisted video system. Neurol Res 1999;21:89–95.
35.
Johansson JD, Loyd D, Wardell K, Wren J: Impact of cysts during radiofrequency lesioning in deep brain structures – a simulation and in vitro study. J Neural Eng 2007;4:87–95.
36.
Jeanmonod D, Werner B, Morel A, Michels L, Zadicario E, Schiff G, Martin E: Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg Focus 2012;32:E1.
37.
Antonsson J, Eriksson O, Lundberg P, Wardell K: Optical measurements during experimental stereotactic radiofrequency lesioning. Stereotact Funct Neurosurg 2006;84:118–124.
38.
Wardell K, Blomstedt P, Richter J, Antonsson J, Eriksson O, Zsigmond P, Bergenheim AT, Hariz MI: Intracerebral microvascular measurements during deep brain stimulation implantation using laser Doppler perfusion monitoring. Stereotact Funct Neurosurg 2007;85:279–286.
39.
Johansson JD, Blomstedt P, Haj-Hosseini N, Bergenheim AT, Eriksson O, Wardell K: Combined diffuse light reflectance and electrical impedance measurements as a navigation aid in deep brain surgery. Stereotact Funct Neurosurg 2009;87:105–113.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.